Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Abnormally high levels of anti-collagen type IV IgG antibodies in the serum of patients with a clinically isolated syndrome correlate with an increased risk of conversion to MS.
Sadarzanska-Terzieva B, Tzvetanov P, Hegde V, Al-Hashel JY, Rousseff RТ, Haralanov L, Stamenov B, Atanassova M, Marinova I, Marinova A, Rousseva A. Sadarzanska-Terzieva B, et al. Among authors: stamenov b. Clin Neurol Neurosurg. 2015 Jun;133:30-3. doi: 10.1016/j.clineuro.2015.03.011. Epub 2015 Mar 17. Clin Neurol Neurosurg. 2015. PMID: 25837238
Reversible focal ischemia model in the rat: correlation of somatosensory evoked potentials and cortical neuronal injury.
Marinov M, Schmarov A, Natschev S, Stamenov B, Wassmann H. Marinov M, et al. Among authors: stamenov b. Neurol Res. 1996 Feb;18(1):73-82. doi: 10.1080/01616412.1996.11758609. Neurol Res. 1996. PMID: 8714541
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, de Cordoüe A, Fratacci MD; PERFORM Study Investigators. Bousser MG, et al. Lancet. 2011 Jun 11;377(9782):2013-22. doi: 10.1016/S0140-6736(11)60600-4. Epub 2011 May 25. Lancet. 2011. PMID: 21616527 Clinical Trial.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM; PERFORM Study Investigators. Bousser MG, et al. Cerebrovasc Dis. 2009;27(5):509-18. doi: 10.1159/000212671. Epub 2009 Apr 16. Cerebrovasc Dis. 2009. PMID: 19372653 Clinical Trial.
[Two cases of Hellp syndrome, clinics and therapy].
Khubchev G, Simeonov S, Mateeva N, Iordanova P, Stamenov B. Khubchev G, et al. Among authors: stamenov b. Akush Ginekol (Sofiia). 2006;45(1):48-51. Akush Ginekol (Sofiia). 2006. PMID: 16637320 Bulgarian. No abstract available.
Sneddon's syndrome: echocardiographic, neurological, and immunologic findings.
Baleva M, Chauchev A, Dikova C, Stamenov B, Nikoevski N, Tzankov N, Nikovov K. Baleva M, et al. Among authors: stamenov b. Stroke. 1995 Jul;26(7):1303-4. Stroke. 1995. PMID: 7604431 No abstract available.